Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients.

MLA

Mazel, Benoit, et al. “Advancing Precision Oncology through Systematic Germline and Tumor Genetic Analysis: The Oncogenetic Point of View on Findings from a Prospective Multicenter Clinical Trial of 666 Patients.” Cancer Medicine, vol. 12, no. 18, Sept. 2023, pp. 18786–96. EBSCOhost, https://doi.org/10.1002/cam4.6498.

APA

Mazel, B., Bertolone, G., Baurand, A., Cosset, E., Sawka, C., Robert, M., Gautier, E., Lançon, A., Réda, M., Favier, L., Dérangère, V., Richard, C., Binquet, C., Boidot, R., Goussot, V., Albuisson, J., Ghiringhelli, F., Faivre, L., & Nambot, S. (2023). Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients. Cancer Medicine, 12(18), 18786–18796. https://doi.org/10.1002/cam4.6498

Chicago

Mazel, Benoit, Geoffrey Bertolone, Amandine Baurand, Elodie Cosset, Caroline Sawka, Marion Robert, Elodie Gautier, et al. 2023. “Advancing Precision Oncology through Systematic Germline and Tumor Genetic Analysis: The Oncogenetic Point of View on Findings from a Prospective Multicenter Clinical Trial of 666 Patients.” Cancer Medicine 12 (18): 18786–96. doi:10.1002/cam4.6498.